Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging. - Wikidata - awgldk - TriplyDB

Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

http://www.wikidata.org/entity/Q35665118

about

Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging Lanthanide probes for bioresponsive imaging Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging Oxidation-Responsive, EuII/III-Based, Multimodal Contrast Agent for Magnetic Resonance and Photoacoustic Imaging Contrast agents for MRI: 30+ years and where are we going?Redox- and hypoxia-responsive MRI contrast agents.A Eu(II)-Containing Cryptate as a Redox Sensor in Magnetic Resonance Imaging of Living Tissue.Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths Oxidation-responsive Eu(2+/3+)-liposomal contrast agent for dual-mode magnetic resonance imaging.A (Fluoroalkyl)Guanidine Modulates the Relaxivity of a Phosphonate-Containing T1-Shortening Contrast Agent.Aqueous Eu(II)-Containing Complex with Bright Yellow Luminescence Developments in the Coordination Chemistry of Europium(II).Interaction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance Imaging Aqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections.Nanoparticle-based multimodal PET/MRI probes.Structural Features of Europium(II)-Containing Cryptates That Influence Relaxivity.Spectroscopic Characterization of the 3+ and 2+ Oxidation States of Europium in a Macrocyclic Tetraglycinate Complex.Ultra-wide range field-dependent measurements of the relaxivity of Gd1-xEuxVO4 nanoparticle contrast agents using a mechanical sample-shuttling relaxometer.The Role of Coordination Environment and pH in Tuning the Oxidation Rate of Europium(II).Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications.Fluorinated EuII-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging.

P2860

Q24617694-DE6855E7-6239-44A6-A458-1F65C6828743 Q27000361-6E3644F1-50BE-4F2B-ACC5-8E8246D6AE68 Q27013727-FFD886A3-CF81-46BB-A632-7A426F4616E8 Q30359425-F762D10C-9585-4AE0-91DE-E7506EC2840C Q30731463-6A75E8E0-56B4-4C2F-A862-4025E5BBFF1C Q30820031-19FEF50F-DF9F-44C6-B838-476F99CE79F6 Q31000314-416ECEAD-ACF3-4FFE-A88F-9EE8D2DC11C5 Q34071930-24CA8CB3-6E6C-4A18-8E70-02DC679A9C9A Q34429253-65B053E8-0501-4C42-AA67-47CEA5BE3A87 Q35458246-C15B5132-0650-4297-974F-1F1C3524FA79 Q35528676-D8D545B6-05FA-4AFA-BE4D-3CBDFEF6AB05 Q36292078-B7B9B8BE-3633-4376-927A-0C54C4EB1FB2 Q36393668-8426CAFF-4591-40B8-A182-0A4A3EFFCE21 Q37143146-E8F863B7-4F16-4CF8-9CA3-F917FEEBE94E Q37143467-9C2B5131-DF01-494A-9B77-BAC4332BE060 Q38467265-B02CBD1A-2921-4CFA-A56A-714D382D828B Q38657746-E79E681A-7193-4E83-B72E-9A6F79892F40 Q39722949-DA8A7034-D462-4F02-A08F-4376CD6DB842 Q42315392-65575E0C-62DC-4B2F-AAB1-DC9A4AECD3FA Q48191242-1A6B9E40-7D73-4B0B-9E62-FFFD451F15FB Q55069856-CF4AF63A-7C8D-4984-A984-3C6DFD70D674 Q55086950-B5934B21-9E1D-4987-B71C-0140EFF368F5

P2860

Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

http://www.wikidata.org/entity/Q35665118

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@ast

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@en

type

label

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@ast

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@en

prefLabel

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@ast

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@en

P1433

Q35665118-29ADF199-0EC7-41E1-9CD8-AA6FE989E057

P1476

Q35665118-D6FBF6F6-E6D2-41A7-A6BF-0BA89895474A

P2093

Q35665118-1C642582-4DCE-4B17-96BC-78CF43A9A372

Q35665118-496C1951-4C40-4ABE-9A7A-64BE741295BD

Q35665118-5E223F80-6D2F-4148-87D9-CC4761D3775C

Q35665118-DACBE396-D648-40AC-8067-2D106ECD51EE

P2860

Q35665118-0BF9C7EC-B3B0-49F5-B4DE-43E01C0DBAC4

Q35665118-25A3B5A0-DBCA-45BA-AF1E-58A131846794

Q35665118-27DE3B8C-0D00-4073-B4CC-7EE9DC3026F1

Q35665118-32F82D06-1798-46C2-8D46-1B1321578AB9

Q35665118-5746FB69-AD14-46B1-8149-AC8D5940DAC0

Q35665118-5CBDFA06-4625-4ACE-B2C9-942685AB696A

Q35665118-686F7C64-4EF0-46FA-B5D2-B3BCC64F2387

Q35665118-6FD5FC6B-3F29-4296-B02D-FBF6308B5DC7

Q35665118-7B5D6139-E13C-4E8E-9C1A-9EF868AB1B76

Q35665118-7B688166-2FE9-4CE8-B344-DF3100E7843F

P304

Q35665118-AF367850-9FCD-4231-9F38-9E7BDC67503F

P31

Q35665118-6D8CE10B-587E-42F3-8125-412B4AE4F0D8

P356

Q35665118-26738D0C-901A-4194-9E85-03690A36D80A

P407

Q35665118-95579322-0B92-4CE1-8236-D70D47ED850B

P433

Q35665118-1BE795F5-CB39-4414-9046-10AEF76803C7

P478

Q35665118-29DBEE97-85A1-4F3F-8CD1-55BB8C20D8B5

P577

Q35665118-838D45E2-6581-47E3-A822-033F07D37298

P5875

Q35665118-564656C2-6F44-49D4-9FFB-1AD29C09685A

P698

Q35665118-072C9C6B-0817-44B1-8AD9-D275EEAD59F1

P932

Q35665118-45616615-7FC3-4754-8621-C24122E9D47D

P356

P1433

Chemical Communications

P1476

Eu(II)-containing cryptates as ...... th magnetic resonance imaging.

@en

P2093

E Mark Haacke

http://www.w3.org/2001/XMLSchema#string

Jaladhar Neelavalli

http://www.w3.org/2001/XMLSchema#string

Joel Garcia

http://www.w3.org/2001/XMLSchema#string

Matthew J Allen

http://www.w3.org/2001/XMLSchema#string

P2860

Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity

Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.

Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes.

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

EuII-cryptate with optimal water exchange and electronic relaxation: a synthon for potential pO2 responsive macromolecular MRI contrast agents.

GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.

Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength.

Rigid MIIL2Gd2III (M = Fe, Ru) complexes of a terpyridine-based heteroditopic chelate: a class of candidates for MRI contrast agents.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents

P304

12858-12860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C1CC15219J

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51761287

http://www.w3.org/2001/XMLSchema#string

P698

22046588

http://www.w3.org/2001/XMLSchema#string

P932

3255567

http://www.w3.org/2001/XMLSchema#string